tradingkey.logo

tradingkey.logo
怜玢


Evotec SE

EVO
りォッチリストに远加
2.700USD
-0.020-0.74%
終倀 05/15, 16:00ET15分遅れの株䟡
954.92M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Evotec SE 䌁業名

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SEの䌁業情報


䌁業コヌドEVO
䌚瀟名Evotec SE
䞊堎日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)
埓業員数4827
蚌刞皮類Depository Receipt
決算期末Oct 11
本瀟所圚地Essener Bogen 7
郜垂HAMBURG
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Germany
郵䟿番号22419
電話番号4940560810
りェブサむトhttps://www.evotec.com/
䌁業コヌドEVO
䞊堎日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)

Evotec SEの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2024
FY2023
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
他の
37.16M
4.31%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.51%
DCF Advisers, LLC
0.30%
WCM Investment Management
0.18%
Parametric Portfolio Associates LLC
0.05%
他の
97.67%
株䞻統蚈
株䞻統蚈
比率
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.51%
DCF Advisers, LLC
0.30%
WCM Investment Management
0.18%
Parametric Portfolio Associates LLC
0.05%
他の
97.67%
皮類
株䞻統蚈
比率
Sovereign Wealth Fund
1.29%
Investment Advisor
0.74%
Investment Advisor/Hedge Fund
0.51%
Research Firm
0.07%
Hedge Fund
0.06%
他の
97.33%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
81
9.58M
2.69%
-584.61K
2025Q4
76
9.39M
2.97%
--
2025Q3
77
9.39M
2.97%
-16.64K
2025Q2
74
9.40M
2.85%
+334.04K
2025Q1
60
9.08M
2.82%
-923.30K
2024Q4
59
8.93M
2.90%
+634.42K
2024Q3
56
8.37M
3.36%
+770.57K
2024Q2
55
7.62M
2.73%
+2.19M
2024Q1
54
5.00M
2.98%
-5.56M
2023Q4
57
5.71M
1.76%
+4.47M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Dec 31, 2025
Wellington Management Company, LLP
1.80M
0.51%
+367.55K
+25.70%
Dec 31, 2025
DCF Advisers, LLC
1.20M
0.34%
--
--
Dec 31, 2025
WCM Investment Management
559.34K
0.16%
+259.07K
+86.28%
Dec 31, 2025
Parametric Portfolio Associates LLC
184.21K
0.05%
-40.74K
-18.11%
Dec 31, 2025
LPL Financial LLC
94.63K
0.03%
+18.96K
+25.06%
Dec 31, 2025
Envestnet Asset Management, Inc.
70.03K
0.02%
-5.68K
-7.50%
Dec 31, 2025
Millennium Management LLC
102.85K
0.03%
+102.85K
--
Dec 31, 2025
Citadel Advisors LLC
69.52K
0.02%
-26.53K
-27.62%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
59.77K
0.02%
-15.06K
-20.13%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Biotechnology ETF
0.08%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
比率0.08%
ActivePassive International Equity ETF
比率0%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™